114 related articles for article (PubMed ID: 35696696)
21. Epidemiology of malignant cutaneous granular cell tumors: A US population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database.
Mirza FN; Tuggle CT; Zogg CK; Mirza HN; Narayan D
J Am Acad Dermatol; 2018 Mar; 78(3):490-497.e1. PubMed ID: 28989104
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of Prognostic Nomograms for Patients with Duodenal Neuroendocrine Neoplasms.
Sun S; Wang W; He C
Med Sci Monit; 2020 Jun; 26():e922613. PubMed ID: 32564052
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
24. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
[TBL] [Abstract][Full Text] [Related]
25. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
Chen HL; Zhou MQ; Tian W; Meng KX; He HF
PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population-based study.
Zhang P; Wang W; Lu M; Zeng C; Chen J; Li E; Tan H; Wang W; Yu X; Tang Q; Zhao J; Shen L; Li J
Cancer Med; 2018 Sep; 7(9):4361-4370. PubMed ID: 30062861
[TBL] [Abstract][Full Text] [Related]
27. Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality.
Wu J; Sun C; Li E; Wang J; He X; Yuan R; Yi C; Liao W; Wu L
BMC Cancer; 2019 Apr; 19(1):334. PubMed ID: 30961556
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
Yadav S; Sharma P; Zakalik D
Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
[TBL] [Abstract][Full Text] [Related]
29. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC
JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665
[TBL] [Abstract][Full Text] [Related]
30. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
Pan Y; Lu L; Chen J; Zhong Y; Dai Z
J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
[TBL] [Abstract][Full Text] [Related]
31. Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time.
Rauh-Hain JA; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
Am J Obstet Gynecol; 2013 Nov; 209(5):468.e1-468.e10. PubMed ID: 23891626
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms.
Yi Z; Liu R; Hu J; He T; Wang Z; Li Y; Zu X
Clin Genitourin Cancer; 2021 Apr; 19(2):155-161. PubMed ID: 33288452
[TBL] [Abstract][Full Text] [Related]
34. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
35. Pediatric spinal cord astrocytomas: a retrospective study of 348 patients from the SEER database.
Luksik AS; Garzon-Muvdi T; Yang W; Huang J; Jallo GI
J Neurosurg Pediatr; 2017 Jun; 19(6):711-719. PubMed ID: 28362182
[TBL] [Abstract][Full Text] [Related]
36. Prognostic indicators in well-differentiated thyroid carcinoma when controlling for stage and treatment.
Krook KA; Fedewa SA; Chen AY
Laryngoscope; 2015 Apr; 125(4):1021-7. PubMed ID: 25583017
[TBL] [Abstract][Full Text] [Related]
37. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
[TBL] [Abstract][Full Text] [Related]
38. Comparative outcomes of bladder cancer.
Cárdenas-Turanzas M; Cooksley C; Pettaway CA; Sabichi A; Grossman HB; Elting L
Obstet Gynecol; 2006 Jul; 108(1):169-75. PubMed ID: 16816072
[TBL] [Abstract][Full Text] [Related]
39. Relationship status and other demographic influences on survival in patients with ovarian cancer.
Gardner AB; Sanders BE; Mann AK; Liao CI; Eskander RN; Kapp DS; Chan JK
Int J Gynecol Cancer; 2020 Dec; 30(12):1922-1927. PubMed ID: 32920535
[TBL] [Abstract][Full Text] [Related]
40. Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis.
Jackson MW; Rusthoven CG; Jones BL; Kamdar M; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):126-132. PubMed ID: 26547384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
